<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Huang Decker | Activity</title>
	<link>https://brycefoster.com/members/canvasraft97/activity/</link>
	<atom:link href="https://brycefoster.com/members/canvasraft97/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Huang Decker.</description>
	<lastBuildDate>Wed, 01 Jul 2026 22:32:32 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">86a9fb4d62118d2c1a82946dfe87bff1</guid>
				<title>Huang Decker posted an update: Navigating the GLP-1 Landscape in Germany: A Comprehensive [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1521209/</link>
				<pubDate>Sun, 05 Apr 2026 13:38:28 +0000</pubDate>

									<content:encoded><![CDATA[<p>Navigating the GLP-1 Landscape in Germany: A Comprehensive Guide to Access, Regulations, and Purchase</p>
<p>In recent years, the pharmaceutical landscape has actually been changed by a class of medications called GLP-1 receptor agonists. Initially established to manage Type 2 diabetes, these drugs have actually gotten global attention for their&hellip;<span class="activity-read-more" id="activity-read-more-1521209"><a href="https://brycefoster.com/activity/p/1521209/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e9c449955c765e18ebd88783179d12ba</guid>
				<title>Huang Decker became a registered member</title>
				<link>https://brycefoster.com/activity/p/1521140/</link>
				<pubDate>Sun, 05 Apr 2026 13:21:36 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>